Effects of Photobiomodulation (PBM) on Pain After Presentation of Aphthous Ulcers in Pediatric Dental Patients
Effects of Photobiomodulation on Pain After Presentation of Aphthous Ulcers in Pediatric Dental Patients
The University of Texas Health Science Center, Houston
30 participants
Mar 10, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to compare the efficacy of laser photobiomodulation and "Magic Mouthwash" for treatment of pain in pediatric patients with aphthous ulcers , to assess how photobiomodulation influences the rate of healing of aphthous ulcers in pediatric patients and to measure changes in pain levels reported by pediatric patients undergoing photobiomodulation treatment for aphthous ulcers.
Eligibility
Inclusion Criteria4
- Patient/guardian speaks either English or Spanish
- Patient presenting with one or more aphthous ulcers in their mouth, identified during a scheduled dental appointment
- No previous PBM treatment to the presenting aphthous ulcer(s)
- Guardian able to partake in a follow-up phone call in either the English or Spanish language
Exclusion Criteria3
- Patient presents with aphthous ulcers recently treated with PBM
- Patient presents with herpes labialis (cold sores)
- Patients presents with systemic disease that affects soft tissue/mucous healing
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
patients will receive PBM therapy using the Biolase Epic pro laser. An average power of 0.6w (peak power = 80w, rep. rate= 20Hz). Each aphthous ulcer will be irradiated one time for a total of 30 seconds via continuous wave.
1:1 mixture of Maalox and Benadryl will be applied to the ulcer as needed for pain. Applications typically will be applied before eating to form a dissolvable oral band-aid that lasts for up to 30 minutes. 10 milliliters of 1:1 Maalox: Benadryl solution will be provided to the family. During the presenting appointment, the patient/family will be shown how to use the 1:1 Maalox: Benadryl solution. It will be applied topically with no rinsing needed.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06819033